Pharmaids Pharmaceuticals Board to Consider Q2 FY27 Results on 11th Nov'26
Pharmaids Pharmaceuticals Ltd 路 Intimation 路 11 Nov 2026, 5:30 am
Pharmaids Pharmaceuticals Board to Consider Q2 FY27 Results on 11th Nov'26 Pharmaids Pharmaceuticals Ltd scheduled a Board of Directors meeting on 11th Nov'26 to consider and approve standalone and consolidated unaudited financial results for the quarter and half-year ended 30th Sep'26. Per insider trading regulations, the trading window for dealing in company securities has been closed since 1st Oct'26 and will reopen 48 hours after the declaration of financial results.
Original exchange filing (PDF)
More announcements from Pharmaids Pharmaceuticals Ltd
- Submission of unaudited financial results for quarter and half year ended 30th September 2026 路 12 Nov 2026
- outcome of the Board Meeting held on Wednesday November 11 2026 i.e today to consider and approve unaudited financial results for the quarter and half year ended September 30 2026 路 12 Nov 2026
- Pursuant to the Regulation 30(3) & 30(4) read with Para B of Part A of Schedule III of SEBI (Listing Obligations and Disclosure requirements) Regulations 2015, we hereby inform that the .... 路 16 Sept 2026
- Voting Results along with the Scrutinizer''s Report of the 37th AGM of the Company held on 11th September 2026 through VC/ OAVM. 路 15 Sept 2026
- Outcome of the 37th Annual General Meeting of the Company held on September 11, 2026 i.e., today at 12 noon through VC/OAVM. 路 11 Sept 2026
- Annual Report 路 18 Aug 2026
- Notice of 37th AGM and Annual Report 路 18 Aug 2026
- Submission of unaudited financial results 路 13 Aug 2026
